Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

MRK

Merck & Co Inc

Feb 06 • 04:00PM ET

121.93

+2.18 1.82 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE AZN-D NVS BMY JNJ AMGN ABBV GSK LLY SNY

| Held by: VTI VOO IVV SPY SCHD VTV XLV VIG VYM DGRO

Index	DJIA, S&P 500	P/E	16.76	EPS (ttm)	7.28	Insider Own	0.13%	Shs Outstand	2.48B	Perf Week	10.57%
Market Cap	302.63B	Forward P/E	12.45	EPS next Y	9.79	Insider Trans	-5.95%	Shs Float	2.48B	Perf Month	12.27%
Enterprise Value	325.81B	PEG	2.09	EPS next Q	-1.50	Inst Own	79.63%	Short Float	1.36%	Perf Quarter	44.48%
Income	18.25B	P/S	4.66	EPS this Y	-41.67%	Inst Trans	-1.03%	Short Ratio	2.30	Perf Half Y	51.71%
Sales	65.00B	P/B	5.85	EPS next Y	86.97%	ROA	15.41%	Short Interest	33.65M	Perf YTD	15.84%
Book/sh	20.85	P/C	16.58	EPS next 5Y	5.95%	ROE	39.51%	52W High	122.43 -0.41%	Perf Year	35.98%
Cash/sh	7.35	P/FCF	23.19	EPS past 3/5Y	8.43% 21.23%	ROIC	19.88%	52W Low	73.31 66.32%	Perf 3Y	13.97%
Dividend Est.	3.25 (2.66%)	EV/EBITDA	10.92	Sales past 3/5Y	3.60% 9.37%	Gross Margin	81.50%	Volatility	3.71% 2.65%	Perf 5Y	65.30%
Dividend TTM	3.28 (2.69%)	EV/Sales	5.01	EPS Y/Y TTM	58.02%	Oper. Margin	41.18%	ATR (14)	3.06	Perf 10Y	152.36%
Dividend Ex-Date	Mar 16, 2026	Quick Ratio	1.44	Sales Y/Y TTM	1.61%	Profit Margin	28.08%	RSI (14)	78.08	Recom	1.97
Dividend Gr. 3/5Y	5.42% 5.75%	Current Ratio	1.66	EPS Q/Q	-19.28%	SMA20	9.51%	Beta	0.28	Target Price	121.26
Payout	45.05%	Debt/Eq	0.80	Sales Q/Q	7.24%	SMA50	14.53%	Rel Volume	0.90	Prev Close	119.75
Employees	75000	LT Debt/Eq	0.77	Earnings	Feb 03 BMO	SMA200	37.25%	Avg Volume	14.61M	Price	121.93
IPO	Jun 15, 1946	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.43% 1.24%	Trades		Volume	13,079,052	Change	1.82%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-26	Upgrade	Wolfe Research	Peer Perform → Outperform	$135
Dec-18-25	Upgrade	BMO Capital Markets	Market Perform → Outperform	$130
Nov-24-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$125
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$105
Oct-13-25	Resumed	Citigroup	Neutral	$95
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$90
May-14-25	Downgrade	Citigroup	Buy → Neutral	$84
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$85
Feb-18-25	Downgrade	Deutsche Bank	Buy → Hold	$128 → $105
Feb-10-25	Downgrade	TD Cowen	Buy → Hold	$121 → $100
Jan-08-25	Downgrade	Truist	Buy → Hold	$110
Dec-20-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$136 → $105
Dec-10-24	Resumed	BofA Securities	Buy	$121
Dec-04-24	Upgrade	HSBC Securities	Hold → Buy	$130
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-11-24	Downgrade	Daiwa Securities	Buy → Neutral
Oct-17-24	Initiated	Bernstein	Mkt Perform	$115
Mar-11-24	Downgrade	Societe Generale	Hold → Sell	$104
Jan-04-24	Upgrade	TD Cowen	Market Perform → Outperform	$125 → $135
Nov-09-23	Initiated	Deutsche Bank	Buy	$115

Show Previous Ratings

Feb-07-26 11:50AM	Merck & Co., Inc. (MRK): A Bull Case Theory (Insider Monkey)
Feb-06-26 04:15PM	The Dow Industrials Have Tilted More Toward Financials (The Wall Street Journal)
12:53PM	Big-Name Earnings, Selloffs Highlight Busy Week on Wall Street (Schaeffer's Research)
11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
11:04AM	Merck's Subdued 2026 Outlook: What it Means After Q4 Results? (Zacks)
09:28AM	Loading…
09:28AM	Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic (Zacks)
07:08AM	White Houses online service for drug sales debuts with limited impact on prices (BioPharma Dive)
Feb-05-26 02:38PM	Scotiabank Lifts Merck (MRK) Target as Execution Continues to Impress (Insider Monkey)
01:21PM	Merck veteran Perlmutter-led Eikon Therapeutics valued at $860 million in Nasdaq debut (Reuters)
09:15AM	Should You Buy, Hold, or Sell GILD Stock Ahead of Q4 Earnings? (Zacks)
08:31AM	AstraZeneca to Report Q4 Earnings: What's in Store for the Stock? (Zacks)
07:58AM	Rapid Innovation is Reshaping Oncology: Stocks in Focus (Zacks)
05:44AM	J.P. Morgan Healthcare Conference 2026 Report (Pharmaceutical Technology)
03:00AM	Big Pharma CEOs set sights on massive growth in years to come (Pharma Voice)
Feb-04-26 03:18PM	Jim Cramer on Merck & Co.: "This Is One of My Favorite Pharmaceutical Stocks" (Insider Monkey)
12:16PM	Loading…
12:16PM	S&P 500 Slips, Nasdaq Drops as Traders Dump Chips (Schaeffer's Research)
10:16AM	Stock Market Today: Dow Rises But Nasdaq Lags On Surprise Jobs Data; Eli Lilly Soars (Live Coverage) (Investor's Business Daily)
01:08AM	Merck & Co., Inc. Q4 Earnings Call Highlights (MarketBeat)
12:35AM	MRK Q4 Deep Dive: Pipeline Expansion and New Product Launches Shape Guidance (StockStory)
Feb-03-26 04:26PM	Stocks Tumble on AI Disruption Fears (Barchart)
04:02PM	Merck & Co Inc (MRK) Q4 2025 Earnings Call Highlights: Strong Growth Amidst Challenges (GuruFocus.com)
03:42PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
02:56PM	Pfizer Stock Falls After Solid Earnings. Whats Troubling Wall Street. (Barrons.com)
02:46PM	These Stocks Are Todays Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More (Barrons.com)
02:43PM	Merck Stock Gains as Earnings Top Estimates. Momentum Is Building, Says CEO. (Barrons.com)
12:40PM	MSDs 2026 sales forecast falls short amid patent losses despite strong Q4 (Pharmaceutical Technology)
12:30PM	Dow Hits Record, Nasdaq Sinks as Tech Stocks Retreat (GuruFocus.com)
12:18PM	Merck 2026 Outlook Misses as Gardasil Sales Drop 35% (GuruFocus.com)
12:15PM	Dow's Early Record Fades as Tech Turns South (Schaeffer's Research)
11:36AM	MRK Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '26 View (Zacks)
11:06AM	Loading…
11:06AM	Merck's Annual Outlook Falls Short But Keytruda, Animal Health Segments Grow (Benzinga)
11:04AM	2 Pharma Stocks React to Quarterly Results, Guidance (Schaeffer's Research)
11:00AM	Merck (MRK) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
11:00AM	Market Awaits JOLTS Jobs Report (Zacks)
10:26AM	Q4 Earnings, JOLTS & a Changing of the Disney Guard (Zacks)
10:17AM	Stock Market Today: Dow Inches Higher As Palantir Rallies; Rambus Tumbles (Live Coverage) (Investor's Business Daily)
09:27AM	Here's Why Gilead Sciences Stock Surged 21% in a Month (Zacks)
08:19AM	Pharma stocks slump as Pfizer and Merck report earnings (Quartz)
08:19AM	Merck and Pfizer decline vs the broader market as results released (Quartz)
07:40AM	Merck (MRK) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:24AM	Jim Cramer on Merck & Co.: "I Think It Can Spread Out the Wealth" (Insider Monkey)
07:11AM	Merck shares fall as 2026 guidance disappoints despite solid Q4 results (Investing.com)
06:55AM	Merck's outlook for 2026 comes in lower-than-expected as pipeline faces make-or-break year (MarketWatch)
06:48AM	Merck's (NYSE:MRK) Q4 CY2025 Sales Beat Estimates (StockStory)
06:48AM	Merck Earnings Top Estimates. Why the Stock Is Falling. (Barrons.com)
06:40AM	Merck: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline (Business Wire)
05:00AM	Advanced Micro Devices heads earnings slate (MarketWatch)
04:34AM	Where is Merck & Co. (MRK) Headed According to Wall Street? (Insider Monkey)
04:19AM	Stock Market Today: S&P 500 eyes fresh record as Dow and Nasdaq also called higher; Palantir rises after earnings; gold and silver rebound; AMD results on tap. (MarketWatch)
03:39AM	Stocks to Watch Tuesday: Palantir, Teradyne, AMD (The Wall Street Journal)
03:01AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-02-26 07:00PM	AMD earnings, Netflix-Warner Bros. hearing: What to Watch (Yahoo Finance Video)
06:02PM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
05:46PM	Market Indexes Bounce Back to Start a New Trading Week (Zacks)
11:40AM	Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year (24/7 Wall St.)
11:12AM	Market Awaits January Manufacturing Numbers (Zacks)
10:35AM	Six More Weeks of Q4 Earnings Season? (Zacks)
10:25AM	What's in Store for These 5 Pharma Bigwigs This Earnings Season? (Zacks)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
07:00AM	Option Volatility And Earnings Report For February 2 - 6 (Barchart)
02:13AM	Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-01-26 10:04PM	Merck (MRK) Q4 Earnings Report Preview: What To Look For (StockStory)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 12:35PM	Merck & Co., Inc. (MRK) Joins BofA's "US 1 List" (Insider Monkey)
Jan-30-26 05:45PM	Merck (MRK) Advances While Market Declines: Some Information for Investors (Zacks)
04:57PM	Jobs Report, More Tech Earnings: What to Watch Next Week (The Wall Street Journal)
12:36PM	This Pharma Stock Eyes Entries, Battles For Key Level Amid 68% Earnings Growth (Investor's Business Daily)
09:41AM	Merck & Co. Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
09:09AM	Stock Market Today: Dow Falls On Surprise Inflation Data, Warsh Nomination; Tesla Rallies (Live Coverage) (Investor's Business Daily)
08:49AM	Will BMY's Oncology Collaborations Drive Its Next Growth Phase? (Zacks)
07:50AM	Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings (Zacks)
03:51AM	Heard on the Street Thursday Recap: Gold Swings (The Wall Street Journal)
Jan-29-26 05:50PM	Why the Market Dipped But Merck (MRK) Gained Today (Zacks)
12:28PM	FDA Accepts Summit's Lung Cancer Drug Application, Review Underway (Benzinga)
09:15AM	Curious about Merck (MRK) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
09:00AM	Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jan-28-26 09:05PM	This Stock Is Already Up 58% This Year. Is It a Buy? (Motley Fool)
12:47PM	Pharma Stocks Are Close to 'Breaking Out.' Earnings Could Set Them Free. (Barrons.com)
10:15AM	Merck's Non-Oncology Drugs Q4 Performance: What to Expect (Zacks)
10:00AM	AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
09:30AM	Brokers Suggest Investing in Merck (MRK): Read This Before Placing a Bet (Zacks)
Jan-27-26 03:07PM	Merck Announces Second-Quarter 2026 Dividend (Business Wire)
02:51PM	3 Healthcare ETFs to Buy as Flat Medicare Rate Proposal Hits Insurers (Zacks)
12:51PM	Kazia Therapeutics Reports Positive Early Responses In Aggressive Breast Cancer Trial (Benzinga)
10:53AM	RVMD Stock Tumbles as MRK Reportedly Withdraws Buyout Offer (Zacks)
10:50AM	Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks (PR Newswire)
10:45AM	Pfizer, Merck, CoreWeave, Zoom: Top Analyst Calls (Yahoo Finance Video)
10:37AM	2 Pharmaceutical Stocks Set to Rebound in 2026 (Motley Fool)
10:00AM	Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
02:14AM	Merck's (MRK) Quality is Clear, but Growth Visibility Matters, TD Cowen Notes (Insider Monkey)
Jan-26-26 07:36PM	Why Revolution Medicines Stock Plummeted by Almost 17% Today (Motley Fool)
04:56PM	Stocks to Watch Monday Recap: CoreWeave, IonQ, USA Rare Earth, RevMed (The Wall Street Journal)
01:48PM	Stocks to Watch Monday: CoreWeave, IonQ, USA Rare Earth, RevMed (The Wall Street Journal)
01:12PM	Stock Market Today: Trump's Medicare announcement slams health insurers (TheStreet)
12:47PM	Merck Ends Acquisition Talks With Revolution Medicines After Valuation Dispute (GuruFocus.com)
11:15AM	Moderna (MRNA) Stock Pulls Back After Recent Strength (Benzinga)
09:09AM	Revolution Medicines stock falls after Merck reportedly ends acquisition pursuit (Investing.com)
07:52AM	Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday? (Benzinga)
07:19AM	MSD ends takeover talks with Revolution Medicines (Pharmaceutical Technology)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RICHARD ROBERT DELUCA JR.	Officer	Feb 06 '26	Proposed Sale	120.92	37,685	4,557,025		Feb 06 04:35 PM
DAVID WILLIAMS	Officer	Feb 06 '26	Proposed Sale	121.91	5,000	609,525		Feb 06 04:33 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 06 '26	Option Exercise	77.62	5,000	388,100	35,838	Feb 06 04:20 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 06 '26	Sale	121.91	5,000	609,525	30,838	Feb 06 04:20 PM
JOHANNES JACOBUS OOSTHUIZEN	Officer	Feb 06 '26	Proposed Sale	121.87	15,000	1,827,992		Feb 06 04:19 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Feb 04 '26	Option Exercise	62.07	4,000	248,280	14,605	Feb 06 04:18 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Feb 04 '26	Sale	119.67	6,400	765,920	8,205	Feb 06 04:18 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 06 '26	Sale	121.87	15,000	1,827,992	21,197	Feb 06 04:15 PM
Litchfield Caroline	EVP & CFO	Feb 04 '26	Option Exercise	53.06	41,997	2,228,361	132,189	Feb 06 04:13 PM
Litchfield Caroline	EVP & CFO	Feb 04 '26	Sale	119.61	41,997	5,023,312	90,192	Feb 06 04:13 PM
Li Dean Y	Executive VP & President, MRL	Feb 04 '26	Option Exercise	56.04	15,087	845,475	117,357	Feb 06 04:12 PM
Li Dean Y	Executive VP & President, MRL	Feb 04 '26	Sale	118.77	15,087	1,791,824	102,270	Feb 06 04:12 PM
Guindo Chirfi	Chief Marketing Officer	Feb 05 '26	Sale	121.88	20,000	2,437,676	80,615	Feb 06 04:10 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Feb 06 '26	Sale	120.92	37,685	4,557,025	160,174	Feb 06 04:08 PM
Davis Robert M	Chairman, CEO & President	Feb 04 '26	Sale	118.04	47,434	5,599,327	443,602	Feb 06 04:05 PM
CHIRFI GUINDO	Officer	Feb 05 '26	Proposed Sale	121.88	20,000	2,437,676		Feb 05 04:25 PM
DALTON SMART	Officer	Feb 04 '26	Proposed Sale	119.67	6,400	765,920		Feb 04 04:38 PM
ROBERT M. DAVIS	Officer	Feb 04 '26	Proposed Sale	118.02	47,434	5,598,137		Feb 04 04:29 PM
DEAN LI	Officer	Feb 04 '26	Proposed Sale	118.77	15,087	1,791,824		Feb 04 04:27 PM
CAROLINE A LITCHFIELD	Officer	Feb 04 '26	Proposed Sale	119.61	41,997	5,023,312		Feb 04 04:26 PM
Downing Cristal N	Chief Comm. & Public Afrs Ofcr	Nov 10 '25	Sale	87.00	7,085	616,395	0	Nov 12 04:01 PM
CRISTAL DOWNING	Officer	Nov 10 '25	Proposed Sale	87.00	7,085	616,395		Nov 10 04:07 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Nov 03 '25	Sale	83.59	8,614	720,040	24,578	Nov 04 04:02 PM
DAVID WILLIAMS	Officer	Nov 03 '25	Proposed Sale	83.59	8,614	720,040		Nov 03 04:09 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Aug 04 '25	Option Exercise	79.29	17,119	1,357,366	41,445	Aug 05 08:46 AM
Guindo Chirfi	Chief Marketing Officer	Aug 04 '25	Option Exercise	79.29	36,903	2,926,039	107,409	Aug 05 08:43 AM
Smart Dalton E. III	SVP Fin. - Global Controller	May 03 '25	Option Exercise	83.18	2,050	170,519	10,127	May 05 04:23 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 30 '25	Option Exercise	84.71	464	39,305	8,242	May 02 04:18 PM
Smart Dalton E. III	SVP Fin. - Global Controller	May 02 '25	Option Exercise	83.26	381	31,722	8,464	May 02 04:18 PM
Romanelli Joseph	President, Human Health Int?l	May 02 '25	Option Exercise	83.26	2,262	188,334	24,061	May 02 04:14 PM
Romanelli Joseph	President, Human Health Int?l	Apr 30 '25	Option Exercise	84.71	2,063	174,757	22,816	May 02 04:14 PM
Larson Betty D	EVP, Chief HR Officer	Apr 30 '25	Option Exercise	84.71	11,350	961,458	11,350	May 02 04:12 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Option Exercise	58.08	5,000	290,400	12,040	Apr 29 04:04 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Sale	82.76	4,262	352,723	7,778	Apr 29 04:04 PM
DALTON SMART	Officer	Apr 25 '25	Proposed Sale	82.76	4,262	352,723		Apr 25 04:05 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 19 '25	Sale	84.09	8,500	714,745	30,705	Feb 20 04:01 PM
JOHANNES JACOBUS OOSTHUIZEN	Officer	Feb 19 '25	Proposed Sale	84.09	8,500	714,745		Feb 19 05:09 PM
DAVID WILLIAMS	Officer	Feb 13 '25	Proposed Sale	85.34	6,000	512,057		Feb 13 04:10 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 13 '25	Sale	85.34	6,000	512,057	24,123	Feb 13 04:01 PM

BR Broadridge Financial Solutions, Inc daily Stock Chart

Peers: FIS ADP INTU JKHY PAYX GPN SSNC IT

| Held by: VTI VOO VO IVV SPY MOAT VOT VUG VIG IWP

Index	S&P 500	P/E	20.14	EPS (ttm)	9.03	Insider Own	0.50%	Shs Outstand	116.70M	Perf Week	-7.71%
Market Cap	21.24B	Forward P/E	17.63	EPS next Y	10.32	Insider Trans	-22.31%	Shs Float	116.17M	Perf Month	-17.11%
Enterprise Value	24.23B	PEG	1.80	EPS next Q	2.64	Inst Own	92.56%	Short Float	1.85%	Perf Quarter	-16.78%
Income	1.07B	P/S	2.96	EPS this Y	11.16%	Inst Trans	1.10%	Short Ratio	2.59	Perf Half Y	-31.74%
Sales	7.18B	P/B	7.37	EPS next Y	8.56%	ROA	12.65%	Short Interest	2.15M	Perf YTD	-18.49%
Book/sh	24.67	P/C	57.17	EPS next 5Y	9.82%	ROE	41.79%	52W High	271.91 -33.10%	Perf Year	-24.23%
Cash/sh	3.18	P/FCF	15.41	EPS past 3/5Y	15.97% 12.41%	ROIC	18.71%	52W Low	183.30 -0.76%	Perf 3Y	18.60%
Dividend Est.	3.81 (2.09%)	EV/EBITDA	13.74	Sales past 3/5Y	6.29% 8.11%	Gross Margin	31.22%	Volatility	5.36% 2.92%	Perf 5Y	24.54%
Dividend TTM	3.71 (2.04%)	EV/Sales	3.37	EPS Y/Y TTM	40.98%	Oper. Margin	17.56%	ATR (14)	6.28	Perf 10Y	239.64%
Dividend Ex-Date	Dec 12, 2025	Quick Ratio	0.97	Sales Y/Y TTM	7.44%	Profit Margin	14.86%	RSI (14)	24.80	Recom	1.92
Dividend Gr. 3/5Y	11.20% 10.26%	Current Ratio	0.97	EPS Q/Q	100.88%	SMA20	-11.76%	Beta	0.98	Target Price	239.57
Payout	49.60%	Debt/Eq	1.17	Sales Q/Q	7.85%	SMA50	-16.78%	Rel Volume	2.33	Prev Close	193.54
Employees	15000	LT Debt/Eq	0.98	Earnings	Feb 03 BMO	SMA200	-22.61%	Avg Volume	828.05K	Price	181.91
IPO	Mar 22, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.78% 6.80%	Trades		Volume	1,931,941	Change	-6.01%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-04-26	Upgrade	DA Davidson	Neutral → Buy	$228
May-06-25	Initiated	Needham	Buy	$300
Dec-12-24	Resumed	Wolfe Research	Peer Perform
Nov-21-24	Initiated	UBS	Neutral	$250
Oct-17-23	Upgrade	Wolfe Research	Underperform → Peer Perform
Apr-24-23	Initiated	RBC Capital Mkts	Outperform	$169
Dec-14-22	Initiated	Morgan Stanley	Equal-Weight	$160
Aug-13-21	Resumed	JP Morgan	Overweight	$181
Feb-03-21	Upgrade	BTIG Research	Neutral → Buy	$176
Dec-18-20	Initiated	Truist	Buy	$175
Aug-12-20	Downgrade	BTIG Research	Buy → Neutral
Aug-05-20	Downgrade	DA Davidson	Buy → Neutral
Feb-28-20	Upgrade	Raymond James	Mkt Perform → Outperform	$130
Feb-26-20	Initiated	BTIG Research	Buy	$135
Feb-03-20	Upgrade	DA Davidson	Neutral → Buy	$134 → $138
Jul-31-19	Downgrade	Raymond James	Outperform → Mkt Perform
May-08-19	Downgrade	DA Davidson	Buy → Neutral	$128
Mar-13-19	Upgrade	Raymond James	Mkt Perform → Outperform	$118
Feb-08-19	Upgrade	DA Davidson	Neutral → Buy	$116
Aug-29-18	Initiated	SunTrust	Buy	$150

Show Previous Ratings

Feb-06-26 08:06PM	Veeco Instruments Shareholders Approve Axcelis Merger Deal, Exec Pay Plan at Special Meeting (MarketBeat) -6.01%
02:16PM	Broadridge Accelerates Trading Innovation With CQG Acquisition (Benzinga)
08:23AM	SEMrush Stockholders Approve Adobe Acquisition Deal at Special Meeting, Back Merger Pay Plan (MarketBeat)
07:06AM	PennantPark Floating Rate Capital Holds Virtual Annual Meeting, Reelects Penn & Briones, OKs RSM Auditors (MarketBeat)
07:00AM	CQG Enters into Agreement for Acquisition by Broadridge (PR Newswire)
07:00AM	Loading…
07:00AM	Broadridge to Acquire CQG, Expanding Global Futures and Options Trading Capabilities (PR Newswire)
Feb-05-26 09:35AM	Here's Why Broadridge Financial (BR) is Poised for a Turnaround After Losing 13.4% in 4 Weeks (Zacks)
09:00AM	Broadridge price target lowered to $245 from $265 at RBC Capital (TipRanks)
04:06AM	Atmos Energy Shareholders Approve All 8 Proposals, Elect 12 Directors at Annual Meeting (MarketBeat)
Feb-04-26 09:00AM	Broadridge to Participate in Upcoming Investor Events (PR Newswire)
12:30AM	BR Q4 Deep Dive: Revenue Growth Led by Governance and Tokenization, Margins Face Headwinds (StockStory)
Feb-03-26 07:07PM	Golub Capital BDC Virtual Annual Meeting: Golub, Rival Elected; Ernst & Young Auditor Ratified (MarketBeat) -6.25%
06:07PM	Broadridge Financial Solutions Q2 Earnings Call Highlights (MarketBeat)
04:02PM	Broadridge Financial Solutions Inc (BR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
11:30AM	Broadridge's Q2 Earnings and Revenues Outpace Estimates, Rise Y/Y (Zacks)
10:51AM	Loading…
10:51AM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
09:30AM	Here's What Key Metrics Tell Us About Broadridge Financial (BR) Q2 Earnings (Zacks)
09:03AM	Broadridge raises annual profit forecast on investor communications strength (Reuters)
08:20AM	Broadridge (NYSE:BR) Delivers Impressive Q4 CY2025 (StockStory)
08:10AM	Broadridge Financial Solutions (BR) Tops Q2 Earnings and Revenue Estimates (Zacks)
07:10AM	Broadridge Financial: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Broadridge Reports Second Quarter Fiscal 2026 Results (PR Newswire)
Feb-02-26 08:56PM	Broadridge Financial Solutions, Inc. (BR): A Bull Case Theory (Insider Monkey)
05:30PM	Broadridge Appoints Trish Mosconi and Chris Perry to its Board of Directors (PR Newswire)
08:30AM	Advisors Signal Desire for More Technology and Product Education to Drive Growth in New Study from Broadridge and FSI (PR Newswire)
Feb-01-26 10:12PM	Broadridge (BR) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
01:34PM	Visa Shareholders Approve Directors, Pay Plan and Charter Amendments; Reject 4 Proposals at AGM (MarketBeat)
Jan-31-26 02:02AM	Tharimmune Shareholders Approve Directors, Warrant-Linked Share Issuances and 7M Share Plan Boost (MarketBeat)
Jan-30-26 06:52AM	Wells Fargo launches internal proxy voting service (ESG Dive)
Jan-29-26 07:14AM	Wells Fargo switches to in-house proxy voting system (Private Banker International)
09:10AM	Loading…
Jan-28-26 09:10AM	Broadridge Set to Report Q2 Earnings: What's in the Cards? (Zacks)
06:00AM	Wells Fargo Cuts Proxy Adviser Ties in Latest Blow to Industry (The Wall Street Journal)
Jan-24-26 09:01AM	Broadridge price target lowered to $228 from $240 at DA Davidson (TipRanks)
Jan-23-26 12:48PM	Intuit Stockholders Re-Elect Directors, Back Say-on-Pay; DEI ROI Proposal Fails at AGM (MarketBeat)
Jan-22-26 07:00AM	Broadridge Recognized as One of FORTUNE Magazine's 2026 'World's Most Admired Companies' (PR Newswire)
Jan-21-26 06:01AM	Broadridge Schedules Webcast and Conference Call to Review Second Quarter Fiscal Year 2026 Results on February 3, 2026 (PR Newswire)
Jan-15-26 11:01PM	2 Reasons to Watch BR and 1 to Stay Cautious (StockStory)
Jan-13-26 04:37PM	Top Analyst Reports for Netflix, Toyota Motor & Amphenol (Zacks)
Jan-12-26 10:04AM	Do Options Traders Know Something About Broadridge Stock We Don't? (Zacks)
Jan-08-26 03:00AM	Broadridge's Distributed Ledger Repo Platform Processes Nearly $9 Trillion in December (PR Newswire)
01:00AM	Broadridge Invests in DeepSee, Further Harnessing Agentic AI to Transform Post-trade Operations (PR Newswire)
Jan-06-26 03:00AM	Broadridge Completes Acquisition of Acolin, Unlocking Seamless Cross-Border Distribution and Enhanced Data-Driven Solutions for Clients (PR Newswire)
Jan-05-26 04:56AM	Broadridge Financials Q2 2026 Earnings: What to Expect (Barchart)
Jan-02-26 11:24AM	Reasons Why You Should Hold On to Broadridge Stock Right Now (Zacks)
Dec-18-25 07:20PM	Is Broadridge Financial Solutions the Next Big Investment Opportunity? (Motley Fool)
Dec-16-25 03:00AM	Broadridge Strengthens Platform for Alternative Investment Managers with New General Ledger Capabilities and a Redesigned User Interface (PR Newswire)
Dec-15-25 09:30AM	Earnings Growth & Price Strength Make Broadridge Financial Solutions (BR) a Stock to Watch (Zacks)
Dec-10-25 08:00AM	Best 25 Stocks to Own Over 2nd Half of December (Schaeffer's Research)
04:59AM	Is Broadridge Financial Stock Underperforming the Dow? (Barchart)
Dec-08-25 02:00AM	Broadridge's Shareholder Disclosure Hub Migrates to AWS, Boosting Global Reach, Resilience and Security (PR Newswire)
Dec-04-25 11:30AM	Why Is Broadridge Financial (BR) Up 5.4% Since Last Earnings Report? (Zacks)
02:00AM	Broadridge's Distributed Ledger Repo Platform Processes $368 Billion in Average Daily Trade Volumes in November (PR Newswire)
Dec-02-25 09:30AM	Why Broadridge Financial Solutions (BR) is a Top Stock for the Long-Term (Zacks)
07:30AM	Broadridge Named a Leader in Wealth Management Technology in IDC MarketScape 2025 Assessment (PR Newswire)
Nov-25-25 10:33PM	Data & Business Process Services Stocks Q3 Earnings: Broadridge (NYSE:BR) Best of the Bunch (StockStory)
Nov-21-25 09:30AM	Why Broadridge Financial Solutions (BR) is a Top Stock for the Long-Term (Zacks)
07:30AM	AI, Product Innovation, and Next-Generation Investors Set the Course for the Future of Asset and Wealth Management, MMI-Broadridge Survey Finds (PR Newswire)
03:28AM	Is Wall Street Bullish or Bearish on Broadridge Financial Solutions Stock? (Barchart)
Nov-19-25 02:00AM	Broadridge and Xceptor Partner to Transform Global Tax Reclaims and Asset Servicing Operations (PR Newswire)
Nov-18-25 11:25AM	Société Générales SG-FORGE Issues First Tokenized Bond in U.S. (CoinDesk)
08:41AM	Broadridge's Tokenization Capability Enables Societe Generale's First U.S. Digital Bond Issuance (PR Newswire)
06:30AM	Perception of Customer Experience at a New Low, Survey from Broadridge Reveals (PR Newswire)
Nov-13-25 12:02PM	Broadridge Declares Quarterly Dividend of $0.975 Per Share (PR Newswire)
02:00AM	Broadridge Appoints Richard Street as Head of International Sales (PR Newswire)
Nov-10-25 09:00AM	U.S. Treasury Central Clearing Survey: U.S. Firms Have High Degree of Confidence in Readiness While Europe and Asia Lag; Regulatory Clarity is a Key Factor (PR Newswire)
02:00AM	Broadridge's Distributed Ledger Repo Platform Processes $385 Billion in Average Daily Trade Volumes in October (PR Newswire)
Nov-07-25 01:46PM	1 Oversold Stock Set for a Comeback and 2 We Brush Off (StockStory)
Nov-05-25 09:45AM	Why Broadridge Financial Solutions (BR) is a Top Growth Stock for the Long-Term (Zacks)
Nov-04-25 04:06PM	Broadridge Financial Solutions Inc (BR) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
01:51PM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
01:32PM	Broadridge's Q1 Earnings and Revenues Outpace Estimates, Rise Y/Y (Zacks)
09:30AM	Broadridge Financial (BR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:42AM	Broadridge (NYSE:BR) Delivers Impressive Q3 (StockStory)
08:10AM	Broadridge Financial Solutions (BR) Q1 Earnings and Revenues Top Estimates (Zacks)
07:29AM	Fintech Broadridge's profit doubles on investor communications unit strength (Reuters)
07:09AM	Broadridge Financial: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Broadridge Reports First Quarter Fiscal 2026 Results (PR Newswire)
Nov-03-25 09:54AM	Tharimmune Stock Gains 30%, on $540M Capital Raise to Build Canton Coin Treasury Strategy (CoinDesk)
Nov-02-25 10:01PM	Broadridge (BR) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-31-25 01:54PM	Broadridge Set to Report Q1 Earnings: What's in the Cards? (Zacks)
Oct-29-25 07:12PM	Analyst Report: Broadridge Financial Solutions, Inc. (Morningstar Research)
Oct-27-25 04:15PM	Tokenization Moving from Hype to Reality Across Financial Services, Broadridge Report Reveals (PR Newswire)
Oct-23-25 07:00AM	Broadridge Partners with LPL Financial to Win 2025 Datos Impact Award for Best Innovation in Client Engagement & Communication (PR Newswire)
Oct-21-25 04:54AM	Broadridge Financial Solutions Earnings Preview: What to Expect (Barchart)
Oct-20-25 04:30PM	Broadridge Schedules Webcast and Conference Call to Review First Quarter Fiscal Year 2026 Results on November 4, 2025 (PR Newswire)
09:45AM	Here's Why Broadridge Financial Solutions (BR) is a Strong Growth Stock (Zacks)
Oct-19-25 05:30AM	Fintech can be catalyst to make Hong Kong a next-level financial hub: Broadridge CEO (South China Morning Post)
Oct-16-25 02:00AM	Asset Servicing Volumes Surge 25% YOY, Triggering a New Era of Automation and Efficiency, New Broadridge Study Finds (PR Newswire)
Oct-15-25 12:33PM	Block & Grubhub Team Up to Upgrade Food Ordering Ecosystem (Zacks)
Oct-14-25 07:00AM	Institutional Support for Shareholder Proposals Hits New Low, Broadridge ProxyPulse Report Finds (PR Newswire)
Oct-13-25 02:00AM	Broadridge's Distributed Ledger Repo Platform Processes $339 Billion in Average Daily Trade Volumes in September (PR Newswire)
Oct-09-25 01:09PM	Block's Square Adds New Features to Square AI, Launches Square Bitcoin (Zacks)
Oct-07-25 10:17AM	State Streets flagship S&P 500 ETF suffers record $32bn outflows (Financial Times)
Oct-03-25 09:45AM	Why Broadridge Financial Solutions (BR) is a Top Growth Stock for the Long-Term (Zacks)
Oct-01-25 12:40PM	Canton Network Activity Surges as Exchanges Join Validators: Copper Research (CoinDesk)
Sep-29-25 02:30AM	Digital Asset Adoption Accelerates Alongside Distributed Ledger Technology Implementation, Broadridge DLT in the Real World Study Finds (PR Newswire)
02:00AM	Merck Selects Broadridge to Transform Treasury Operations with Real-Time Account Visibility (PR Newswire)
Sep-25-25 07:00AM	Broadridge and WealthFeed Partner to Offer End-to-End Advisor Lead Generation and Intelligent Nurturing (PR Newswire)
03:00AM	Broadridge Successfully Delivers ISO 20022 Cash Messaging Capabilities for its Post-Trade Clients (PR Newswire)
Sep-19-25 10:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)

Broadridge Financial Solutions, Inc. engages in the provision of investor communications and technology solutions to banks, broker-dealers, mutual funds, and corporate issuers. It operates through Investor Communication Solutions and Global Technology and Operations segments. The Investor Communication Solutions segment offers services for broker-dealer investor communication, customer communication, corporate issuer, advisor solutions, and mutual fund and retirement solutions. The Global Technology and Operations segment includes middle and back-office securities processing solutions, automation services, and business process outsourcing services. The company was founded in 1962 and is headquartered in Lake Success, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROBERT N. DUELKS 2007 REVOCABL	Director	Feb 06 '26	Proposed Sale	192.60	253	48,728		Feb 06 04:14 PM
Duelks Robert N	Director	Feb 06 '26	Sale	192.60	253	48,728	20,815	Feb 06 12:33 PM
Carey Thomas P	Corporate VP	Dec 03 '25	Option Exercise	125.87	10,163	1,279,242	16,240	Dec 04 02:02 PM
Carey Thomas P	Corporate VP	Dec 03 '25	Sale	229.26	10,214	2,341,618	6,026	Dec 04 02:02 PM
THOMAS PATRICK CAREY	Officer	Dec 03 '25	Proposed Sale	229.26	10,214	2,341,618		Dec 03 04:23 PM
CHRISTOPHER J PERRY	Officer	Nov 18 '25	Proposed Sale	226.00	3,984	900,384		Nov 18 04:11 PM
PERRY CHRISTOPHER JOHN	President	Nov 18 '25	Sale	226.00	3,984	900,384	44,829	Nov 18 11:09 AM
Gokey Timothy C	CEO	Aug 25 '25	Sale	258.37	5,674	1,466,010	143,285	Aug 26 10:39 AM
Gokey Timothy C	CEO	Aug 18 '25	Sale	260.87	5,675	1,480,428	148,959	Aug 18 04:25 PM
Gokey Timothy C	CEO	Aug 14 '25	Option Exercise	98.31	99,831	9,814,386	250,205	Aug 15 05:18 PM
Gokey Timothy C	CEO	Aug 13 '25	Option Exercise	93.88	46,561	4,371,147	189,625	Aug 15 05:18 PM
Gokey Timothy C	CEO	Aug 14 '25	Sale	259.53	84,571	21,948,678	165,634	Aug 15 05:18 PM
Gokey Timothy C	CEO	Aug 13 '25	Sale	262.46	39,251	10,301,629	150,374	Aug 15 05:18 PM
Gokey Timothy C	CEO	Aug 15 '25	Sale	259.29	11,000	2,852,158	154,634	Aug 15 05:18 PM
Timothy Gokey	Officer	Aug 14 '25	Proposed Sale	261.68	106,920	27,978,826		Aug 14 04:24 PM
Timothy Gokey	Officer	Aug 13 '25	Proposed Sale	262.50	39,251	10,303,388		Aug 13 04:31 PM
CHRISTOPHER J PERRY	Officer	Aug 12 '25	Proposed Sale	262.72	7,036	1,848,494		Aug 12 04:26 PM
PERRY CHRISTOPHER JOHN	President	Aug 12 '25	Option Exercise	198.30	7,480	1,483,284	55,849	Aug 12 04:20 PM
PERRY CHRISTOPHER JOHN	President	Aug 12 '25	Sale	262.72	7,036	1,848,494	48,813	Aug 12 04:20 PM
LAURA MATLIN	Officer	Aug 07 '25	Proposed Sale	270.56	998	270,019		Aug 07 04:09 PM
DOUGLAS DESCHUTTER	Officer	Jun 06 '25	Proposed Sale	245.76	4,903	1,204,966		Jun 06 04:21 PM
ROBERT N. DUELKS 2007 REVOCABL	Director	Jun 06 '25	Proposed Sale	245.15	500	122,575		Jun 06 04:10 PM
DESCHUTTER DOUGLAS RICHARD	Co-President ICS	Jun 06 '25	Sale	245.76	4,903	1,204,966	16,264	Jun 06 02:34 PM
Duelks Robert N	Director	Jun 06 '25	Sale	245.15	500	122,575	19,858	Jun 06 02:29 PM
Markus Maura A.	Director	Jun 04 '25	Option Exercise	56.37	5,771	325,311	34,448	Jun 05 10:35 AM
Markus Maura A.	Director	Jun 04 '25	Sale	243.08	3,556	864,408	30,892	Jun 05 10:35 AM
MAURA A MARKUS	Director	Jun 04 '25	Proposed Sale	243.08	3,556	864,408		Jun 04 04:06 PM
DESCHUTTER DOUGLAS RICHARD	Co-President ICS	May 27 '25	Sale	239.55	5,056	1,211,161	21,167	May 28 11:54 AM
DOUGLAS DESCHUTTER	Officer	May 27 '25	Proposed Sale	239.55	5,056	1,211,161		May 27 04:40 PM
PAMELA L. CARTER	Director	May 20 '25	Proposed Sale	242.23	4,829	1,169,745		May 20 04:09 PM
Carter Pamela L	Director	May 20 '25	Option Exercise	96.31	6,908	665,290	12,071	May 20 11:38 AM
Carter Pamela L	Director	May 20 '25	Sale	242.23	4,829	1,169,745	7,242	May 20 11:38 AM
Jarkowski Hope M.	Chief Legal Officer	May 15 '25	Sale	240.99	1,069	257,615	1	May 16 03:37 PM
HOPE M JARKOWSKI	Officer	May 15 '25	Proposed Sale	240.99	1,069	257,615		May 15 04:34 PM
Carey Thomas P	Corporate VP	May 13 '25	Sale	237.26	3,607	855,798	6,077	May 14 10:32 AM
THOMAS PATRICK CAREY	Officer	May 13 '25	Proposed Sale	237.26	3,607	855,798		May 13 04:15 PM
RICHARD J STINGI	Officer	May 07 '25	Proposed Sale	234.81	800	187,848		May 07 04:32 PM
Stingi Richard John	Corporate VP and CHRO	May 07 '25	Sale	234.81	800	187,848	5,509	May 07 04:27 PM
Jarkowski Hope M.	Chief Legal Officer	May 07 '25	Sale	235.22	1,068	251,220	1,070	May 07 04:27 PM
HOPE M JARKOWSKI	Officer	May 07 '25	Proposed Sale	235.22	1,068	251,220		May 07 04:04 PM
Stingi Richard John	Corporate VP and CHRO	Apr 01 '25	Option Exercise	0.00	1,511	0	8,041	Apr 03 04:26 PM
Jarkowski Hope M.	Chief Legal Officer	Apr 01 '25	Option Exercise	0.00	3,903	0	3,904	Apr 03 04:26 PM
Gokey Timothy C	CEO	Apr 02 '25	Sale	245.07	11,724	2,873,231	143,064	Apr 03 04:26 PM
Ghei Ashima	Interim CFO	Apr 01 '25	Option Exercise	0.00	1,304	0	4,861	Apr 03 04:26 PM
Timothy Gokey	Officer	Apr 02 '25	Proposed Sale	244.72	11,724	2,869,097		Apr 02 04:12 PM
Gokey Timothy C	CEO	Mar 10 '25	Option Exercise	67.32	59,395	3,998,471	265,744	Mar 12 10:55 AM
Gokey Timothy C	CEO	Mar 10 '25	Sale	235.43	95,956	22,591,278	169,788	Mar 12 10:55 AM
TIM GOKEY	Officer	Mar 10 '25	Proposed Sale	235.90	34,101	8,044,262		Mar 10 04:35 PM
Timothy Gokey	Officer	Mar 10 '25	Proposed Sale	240.92	73,579	17,726,653		Mar 10 04:24 PM
PERRY CHRISTOPHER JOHN	President	Mar 07 '25	Option Exercise	145.79	24,644	3,592,775	74,881	Mar 10 11:33 AM
PERRY CHRISTOPHER JOHN	President	Mar 07 '25	Sale	235.23	22,357	5,259,035	52,524	Mar 10 11:33 AM
CHRISTOPHER J PERRY	Officer	Mar 07 '25	Proposed Sale	235.23	22,357	5,259,035		Mar 07 04:54 PM
Duelks Robert N	Director	Feb 27 '25	Sale	237.93	485	115,395	4,960	Feb 28 11:11 AM
BOMAR II LLC	Director	Feb 27 '25	Proposed Sale	237.93	485	115,395		Feb 27 04:19 PM
ROBERT DUELKS	Director	Feb 26 '25	Proposed Sale	237.15	8,405	1,993,273		Feb 26 04:37 PM
Duelks Robert N	Director	Feb 26 '25	Option Exercise	68.20	14,631	997,860	34,915	Feb 26 03:30 PM
Duelks Robert N	Director	Feb 26 '25	Sale	237.15	8,405	1,993,273	26,510	Feb 26 03:30 PM

MRK

Merck & Co Inc

BR

Broadridge Financial Solutions, Inc

Upgrade your FINVIZ experience